Utilize the data and tweets at hand to foresee if the closing price of $gild will elevate or diminish at 2017-10-16. Only answer with Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-10-02,-2.8,0.1,-2.8,3.1,3.1,-1.1,-0.9,-0.8,-0.6,-1.5,-3.3
2017-10-03,0.4,1.3,-1.3,-0.4,-0.4,-0.8,-0.4,-0.5,-0.1,-0.7,-2.5
2017-10-04,1.0,1.0,-0.4,-0.9,-0.9,-0.3,0.5,0.4,0.8,0.6,-1.2
2017-10-05,-1.5,0.0,-1.7,1.3,1.3,-0.9,-0.7,-0.9,-0.6,-0.6,-2.1
2017-10-06,1.0,1.3,-0.2,-1.6,-1.6,1.0,0.8,0.8,0.9,1.0,-0.1
2017-10-09,0.5,1.0,-0.5,-0.2,-0.2,0.8,0.8,0.9,1.0,1.2,0.4
2017-10-10,-1.4,0.0,-1.4,1.3,1.3,-0.5,-0.6,-0.3,-0.4,-0.1,-0.5
2017-10-11,0.6,0.9,-0.3,-0.6,-0.6,0.1,-0.2,0.2,0.2,0.5,0.4
2017-10-12,1.6,1.9,-0.3,-1.5,-1.5,1.1,1.4,1.7,1.7,1.9,2.0
2017-10-13,0.1,0.5,-0.6,-0.2,-0.2,1.0,1.6,1.7,1.7,1.9,2.0

2017-10-02: rt AT_USER gilead sciences - $gild +3.1% to $83.52. mid term bullish. if &gt;90, then its empty air to the $110 threshold. AT_USER|gilead sciences - $gild +3.1% to $83.52. mid term bullish. if &gt;90,
2017-10-03: rt AT_USER $gild completes acquisition of $kite. congrats to both companies. a look back at kite's 3yrs as a public company. |illumina - $ilmn , settled higher for a 4th day. soft resistance in the $2
2017-10-04: $gild |$gild gilead sciences, inc. sec filing: form 4 |evp comm%26acs ala of gilead sciences just disposed of 7,750 shares   $gild|$gild - statement of changes in beneficial ownership (4) |$gild gilea
2017-10-05: gilead sciences - $gild +1.3% to $83.51, although s/t price action is choppy. a break &gt;90 will offer a fierce run t¡­ |traders sell gilead sciences, inc. $gild on strength after insider selling |rt
2017-10-06: traders buy gilead sciences, inc. $gild on weakness |traders buy gilead sciences, inc. $gild on weakness |traders buy gilead sciences, inc. $gild on weakness |gilead sciences - $gild , settled -1.6% a
2017-10-07: $gild is m/t bullish, first soft target 90, then open air to 110. f' pe 10s, yield 2.5%. technically and fundamenta¡­ |rt AT_USER new dmhc podcast! afrezza update/parps in eu/q4 catalysts $clls $amgn 
2017-10-08: af says: i must have heard this $gild radio spot dozen times over the weekend. also advertising in boston train st¡­ |rt AT_USER i must have heard this $gild radio spot dozen times over the weekend. a
2017-10-10: $gild is in white marubozu winning 66.67% in the past. |rt AT_USER leerink: $abbv abt-494 &amp; $gild filgotinib will take most of ~$12b ra + ibd market. safety disclosures over next 18 mos cd d¡­|AT_
2017-10-11: aapl $hd $amzn $googl $xom $gs $c $jpm $ko $ge $gild $utx $ma $bac $msft $intc $tsla $nflx $csco $dis $pg $mo $rai¡­ |a look at the short interest of theses 6 biotech stocks  $amgn $biib $celg $gild $
2017-10-12: nih, industry in $215m cancer immunotherapy partnership. includes $amgn $bmy $celg $gild $jnj &amp; more...  AT_USER|gilead sciences - $gild -1.5% to $81.30. s/t bearish - with main market, but m/t hy
2017-10-13: rt AT_USER $juno¡¯s brief for the ipr appeal was rejected by the court.  the corrected brief is due later this month. $kite $gild |price returns vs expected daily move $pfe $bmy $gild $abbv $teva $srp
2017-10-14: evening most tweeted big caps, check out gambiste top 10: $nke $hon $pgr $cost $nvda $xom $ibb $gild $crm $axp |rt AT_USER don't miss our next free option trade.  sign up for our daily free trades at 
2017-10-15: don't miss our next free option trade.  sign up for our daily free trades at  $nvda $tsla $gs $gild $biib $googl $fb|5 game-changing cancer drug innovations being developed right now  AT_USER $mrk, $b
Answer:
Utilize the data and tweets at hand to foresee if the closing price of $gild will elevate or diminish at 2017-10-16. Only answer with Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-10-02,-2.8,0.1,-2.8,3.1,3.1,-1.1,-0.9,-0.8,-0.6,-1.5,-3.3
2017-10-03,0.4,1.3,-1.3,-0.4,-0.4,-0.8,-0.4,-0.5,-0.1,-0.7,-2.5
2017-10-04,1.0,1.0,-0.4,-0.9,-0.9,-0.3,0.5,0.4,0.8,0.6,-1.2
2017-10-05,-1.5,0.0,-1.7,1.3,1.3,-0.9,-0.7,-0.9,-0.6,-0.6,-2.1
2017-10-06,1.0,1.3,-0.2,-1.6,-1.6,1.0,0.8,0.8,0.9,1.0,-0.1
2017-10-09,0.5,1.0,-0.5,-0.2,-0.2,0.8,0.8,0.9,1.0,1.2,0.4
2017-10-10,-1.4,0.0,-1.4,1.3,1.3,-0.5,-0.6,-0.3,-0.4,-0.1,-0.5
2017-10-11,0.6,0.9,-0.3,-0.6,-0.6,0.1,-0.2,0.2,0.2,0.5,0.4
2017-10-12,1.6,1.9,-0.3,-1.5,-1.5,1.1,1.4,1.7,1.7,1.9,2.0
2017-10-13,0.1,0.5,-0.6,-0.2,-0.2,1.0,1.6,1.7,1.7,1.9,2.0

2017-10-02: rt AT_USER gilead sciences - $gild +3.1% to $83.52. mid term bullish. if &gt;90, then its empty air to the $110 threshold. AT_USER|gilead sciences - $gild +3.1% to $83.52. mid term bullish. if &gt;90,
2017-10-03: rt AT_USER $gild completes acquisition of $kite. congrats to both companies. a look back at kite's 3yrs as a public company. |illumina - $ilmn , settled higher for a 4th day. soft resistance in the $2
2017-10-04: $gild |$gild gilead sciences, inc. sec filing: form 4 |evp comm%26acs ala of gilead sciences just disposed of 7,750 shares   $gild|$gild - statement of changes in beneficial ownership (4) |$gild gilea
2017-10-05: gilead sciences - $gild +1.3% to $83.51, although s/t price action is choppy. a break &gt;90 will offer a fierce run t¡­ |traders sell gilead sciences, inc. $gild on strength after insider selling |rt
2017-10-06: traders buy gilead sciences, inc. $gild on weakness |traders buy gilead sciences, inc. $gild on weakness |traders buy gilead sciences, inc. $gild on weakness |gilead sciences - $gild , settled -1.6% a
2017-10-07: $gild is m/t bullish, first soft target 90, then open air to 110. f' pe 10s, yield 2.5%. technically and fundamenta¡­ |rt AT_USER new dmhc podcast! afrezza update/parps in eu/q4 catalysts $clls $amgn 
2017-10-08: af says: i must have heard this $gild radio spot dozen times over the weekend. also advertising in boston train st¡­ |rt AT_USER i must have heard this $gild radio spot dozen times over the weekend. a
2017-10-10: $gild is in white marubozu winning 66.67% in the past. |rt AT_USER leerink: $abbv abt-494 &amp; $gild filgotinib will take most of ~$12b ra + ibd market. safety disclosures over next 18 mos cd d¡­|AT_
2017-10-11: aapl $hd $amzn $googl $xom $gs $c $jpm $ko $ge $gild $utx $ma $bac $msft $intc $tsla $nflx $csco $dis $pg $mo $rai¡­ |a look at the short interest of theses 6 biotech stocks  $amgn $biib $celg $gild $
2017-10-12: nih, industry in $215m cancer immunotherapy partnership. includes $amgn $bmy $celg $gild $jnj &amp; more...  AT_USER|gilead sciences - $gild -1.5% to $81.30. s/t bearish - with main market, but m/t hy
2017-10-13: rt AT_USER $juno¡¯s brief for the ipr appeal was rejected by the court.  the corrected brief is due later this month. $kite $gild |price returns vs expected daily move $pfe $bmy $gild $abbv $teva $srp
2017-10-14: evening most tweeted big caps, check out gambiste top 10: $nke $hon $pgr $cost $nvda $xom $ibb $gild $crm $axp |rt AT_USER don't miss our next free option trade.  sign up for our daily free trades at 
2017-10-15: don't miss our next free option trade.  sign up for our daily free trades at  $nvda $tsla $gs $gild $biib $googl $fb|5 game-changing cancer drug innovations being developed right now  AT_USER $mrk, $b
Answer:+Fall